Related Experiment Video
Updated: Dec 13, 2025
11:18
Direct Drug Delivery to Kidney via the Renal Artery
Published on: April 17, 2021
8.0K
Advances in kidney-targeted drug delivery systems
Zhong Chen1, Haisheng Peng1, Changmei Zhang1
1Department of Pharmaceutics, Daqing Campus of Harbin Medical University, 1 Xinyang Rd, Daqing 163319, China.
International Journal of Pharmaceutics
|July 28, 2020
Summary
Nanotechnology offers promising solutions for kidney disease treatment, leveraging nano-based drug delivery systems. This review explores kidney properties and nanomaterial characteristics for effective kidney targeting and therapy.
Area of Science:
- Nephrology
- Biomedical Engineering
- Materials Science
Background:
- Kidney diseases represent a significant global health challenge.
- Current treatments face limitations in efficacy and side effects.
- Nanotechnology presents a novel therapeutic frontier for renal conditions.
Purpose of the Study:
- To review the physiological and anatomical aspects of the kidney relevant to drug targeting.
- To examine the characteristics of nano-based drug delivery systems for kidney therapy.
- To highlight the potential and challenges of nanotechnology in treating kidney diseases.
Main Methods:
- Literature review of kidney physiology and anatomy.
- Analysis of physicochemical properties of nanomaterials for drug delivery.
- Synthesis of current research on nanotechnology applications in nephrology.
Main Results:
- Understanding kidney properties is crucial for effective nano-drug delivery.
- Various nano-based systems show potential for targeted kidney therapy.
- Nanotechnology offers new avenues for managing kidney diseases.
Conclusions:
- Nanotechnology holds significant promise for advancing kidney disease treatment.
- Further research is needed to overcome challenges in clinical translation.
- Nano-based drug delivery systems are key to future renal therapies.
Related Concept Videos
01:15Drug Elimination by Renal Route: Tubular Secretion
3.2K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.2K
01:15Renal Drug Excretion: Overview
506
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
506
01:17Drug Elimination by Renal Route: Glomerular Filtration
6.7K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
6.7K
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
123
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
123
01:06Renal Drug Clearance: Overview
572
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
572
01:16Drug Delivery: Overview
629
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
629